Web Stats Provided By Google Analytics

Monday, June 10, 2013

BioLineRx Ltd. Signs a $30 Million Hepatitis Deal With a Leading Chinese Company

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! BioLineRx Enters into Collaboration to Develop and Commercialize Hepatitis C Drug with CTTQ, Leading Chinese Pharma Company for Liver Disease Therapeutics JERUSALEM-- -- BioLineRx , a biopharmaceutical development company, announced today that it has signed ... (more)

http://www.biospace.com/news_story.aspx?StoryID=299449&full=1

No comments:

Post a Comment